TE
RCUS icon

Tema ETFs’s Arcus Biosciences RCUS Stock Holding History

Tema ETFs’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.56M Buy
83,140
+7,927
+11% +$196K 0.08% 158
2026
Q1 		$1.62M Buy
75,213
+39,088
+108% +$844K 0.11% 171
2025
Q4 		$861K Buy
36,125
+5,832
+19% +$119K 0.07% 263
2025
Q3 		$412K Sell
30,293
-29,369
-49% -$305K 0.03% 410
2025
Q2 		$486K Buy
59,662
+44,411
+291% +$379K 0.13% 139
2025
Q1 		$120K Sell
15,251
-6,982
-31% -$80.9K 0.04% 145
2024
Q4 		$331K Buy
+22,233
New +$363K 0.14% 124

Other funds holding RCUS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SAM
Seelaus Asset Management Chatham, New Jersey $142M AUM 48.54% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Tema ETFs's RCUS Position: Q2 2026 in Review

Tema ETFs increased its Arcus Biosciences (RCUS) stake by 11% in Q2 2026, buying an estimated $196K and bringing the position to 83,140 shares worth $2.56M. The position accounts for 0.08% of the portfolio, ranked #158.

Tema ETFs first reported a position in RCUS in Q4 2024 and has held it in 7 quarters since. 17 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Tema ETFs held 83,140 shares of Arcus Biosciences worth $2.56M as of Q2 2026.
  • Tema ETFs bought 7,927 Arcus Biosciences shares in Q2 2026, an estimated $196K.
  • Arcus Biosciences made up 0.08% of Tema ETFs's portfolio in Q2 2026, its #158 holding.
  • Tema ETFs first reported a position in Arcus Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 17 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.